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Summary
We have cloned a full-length cDNA for the B cell membrane protein CD22, which is referred
to as B lymphocyte cell adhesion molecule (BLCAM). Using subtractive hybridization techniques,
several B lymphocyte-specific cDNAs were isolated. Northern blot analysis with one ofthe clones,
clone 66, revealed expression in normal activated B cells and a variety of B cell lines, but not
in normal activated T cells, T cell lines, Hela cells, or several tissues, including brain and placenta.
One major transcript of -3.3 kb was found in B cells although several smaller transcripts were
also present in low amounts (ti2.6, 2.3, and 1.6 kb) . Sequence analysis of a full-length cDNA
clonerevealed an open reading frame of 2,541 bases coding for a predicted protein of 847 amino
acids with a molecular mass of 95 kD. The B1rCAM cDNA is nearly identical to a recently
isolated cDNA clone for CD22, with the exception of an additional 531 bases in the coding
region of BLCAM. BLCAM has a predicted transmembrane spanning region and a 140-amino
acid intracytoplasmic domain. Search of the National Biological Research Foundation protein
database revealed that this protein is a member of the immunoglobulin super family and that
it had significant homology with three homotypic cell adhesion proteins: carcinoembryonic antigen
(29% identity over 460 amino acids), myelin-associated glycoprotein (27% identity over 425
amino acids), and neural cell adhesion molecule (21.5% over 274 amino acids). Northern blot
analysis revealed low-level BLCAM mRNA expression in unactivated tonsillar B cells, which
was rapidly increased afterB cell activation with Staphylococcus aureus Cowan strain 1 and phorbol
myristate acetate, but not by various cytokines, including interleukin 4 (114), IL6, and y interferon.
In situ hybridization with an antisense BLCAM RNA probe revealed expression in B cell-rich
areas in tonsil and lymph node, although the most striking hybridization was in the germinal
centers. COS cellstransfected with a BLCAMexpression vector were immunofluorescently stained
positively with two different CD22 antibodies, each of which recognizes a different epitope.
Additionally, both normal tonsil B cells and a B cell line were found to adhere to COS transfected
with BIrCAM in the sense but not the antisense direction. Based on the similarity of BLCAM
to other homotypic cell adhesion molecules together with our transfection data, we conclude
that that BIrCAM may be an important mediator of B-B cell interactions and may play a role
in the localization of B lymphocytes in lymphoid tissues.
￿
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ubtractive cDNA cloning has been successfully used to
isolate genes that are expressed in a tissue-specific manner
(1-3). The success ofthis technique depends upon usingcells
or tissues whose mRNA populations are very similar. B and
T lymphocytes differ in only a small fraction oftheir expressed
genes. For example, B and T cell tumors have been estimated
to express only 200-300 unique genes (present in one cell
type and not in another (4). We have been interested in charac-
terizing some of the genes that are expressed uniquely in
human B lymphocytes and have used subtractive cDNA
cloning to isolate a series of cDNA clones that, on the basis
of their mRNA expression, are present in B lymphocytes and
not in a wide variety of other cell types. We have reasoned
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that these B cell-specific genes will encode for proteins im-
portant in human B cell function and, in addition, they will
provide useful tools for understanding the basis oftheir tissue-
specific expression.
One of these cDNA clones encodes for a protein that is
homologous with several homotypic cell adhesion molecules,
appears to mediate cell adhesion among human B cells, and
reacts,with antibodies to the CD22 membrane antigen. We
have referred to this protein as B lymphocyte cell adhesion
molecule (BLCAM). 1 While our work was in progress an-
'Abbreviations used in this paper BIrCAM, B lymphocyte cell adhesion
molecule; CEA, carcinoembryonic-associated antigen; MAG, myelin-
associated glycoprotein; SAC, Staphylococcus aureus Cowan strain 1.
Medicine " Volume 173 January 1991 137-146other groupisolated acDNA for CD22 by expression cloning
in COS cells using CD22 antibodies. COS cells transfected
with CD22 were shown to mediate adhesion to monocytes
and mouse erythrocytes (5). The BITCAM cDNA extends
further 5' and 3' than this cDNA andincludes an additional
531 by in thecoding region that encodesfor 177amino acids
and two immunoglobulin-like domains. The significance of
these findings are discussed.
Materials and Methods
Cell CultureandCellLines.
￿
Humantonsilswere obtained from
5-16-yr-old patients undergoing routine tonsillectomiesforchronic
tonsillitis.Bcell-enriched populations were obtained from tonsillar
mononuclear cells by twice rosetting with aminoethylisothiouro-
nium bromide-treated SRBCsto remove T cells as previously de-
scribed (6). TheB cell preparations were routinely >96% positive
for CD20, <1% CD3*, and <1% esterase positive. B cells were
stimulated in vitroby theaddition of 0.005% Staphylococcus aureus
Cowan strain I(SAC) to theculture media(RPMI 1640 plus 10%
FCS). TheSACwasobtained from Gibco-Bethesda Research labora-
tories (Gaithersburg, MD)andwashed four timeswith PBSbefore
use. The cell linesHS-Sultan, Ramos, IM-9,Jurkat, and Hut 102
were obtained from theAmerican Type CultureCollection (Rock-
ville, MD). The Epstein Barr virus-transformed cell line EBV1
was derived from a spontaneous transformation of tonsil B cells.
The CEM, Sup T1, MJ, and MT-4 T cell lines were a kind gift
of Dr. Scott Koenig (NIAID, NIH, Bethesda, MD), the BJA-B
cell line was a gift from Dr. Edward Oates (University of Miami,
Miami, FL), and the NALM-6 pre-Bcell line was a gift from Dr.
Thomas Tedder (Harvard University, Boston, MA).
SynthesisofHybrid-subtracted cDNA Probe.
￿
Poly(A)mRNA from
PHA (2 ug/ml) and PMA (10 ng/ml) -activated peripheral blood
T cells (36h) andfrom SAC and PMA (10 ng/ml) -activated tonsil
B cells (36 h) were prepared from guanidine thiocyanate-purified
RNAusing oligo(dT) columns (Collaborative Research, Lexington,
MA). The subtracted probes were generated according to estab-
lished methods (7). Briefly, the first strand B cell cDNA was pre-
pared using 5 gg of poly(A) mRNA in the presence of 1 mCi of
"P-dCTP. The RNAwas hydrolyzed and the cDNA purified over
aG50column. tRNA (20Pg) and poly(A) Tcell mRNA (10 gg)
were added to the labeled cDNA. The cDNA and mRNA were
ethanolprecipitated and resuspended in 4 P.l of water and 4 14 of
phosphatebuffer (1 Mphosphate, pH 6.8; 0.2% SDS; and 10 mM
EDTA) in a silanized eppendorftube. The hybridization mixture
was overlayed with 100 pl of paraffin oil, heated to 100°C for 1
min, andincubatedovernightat 68°C. Thesingle-stranded DNA
and double-stranded DNARNA complex were separated on a
hydroxylapatite column (Bio-Rad Laboratories, Cambridge, MA)
andsubsequently, the single-stranded DNAwaspurified on a G50
column. Theprocedurewas repeated asecond time to increase the
efficiency of thesubtraction.Typically, thefast hybridizationresulted
in a 80-90% subtraction andthe second hybridization resulted in
a 30-50% subtraction. The overall subtraction was 90-96%.
Synthesis ofcDNA Library and Plaque Screening.
￿
A combined
oligo(dT) andrandom primed cDNA libraryin X zap (N3 x 106
primary clones before amplification) was generated with the use
of poly(A)-containing mRNA from normal tonsillar B lympho-
cytes stimulated for 36 h with SAC and PMA (8; Stratagene, La
Jolla, CA). The library was plated at low density (4,000 Plaque-
formingunits/150-mm plate), and thenitrocellulose membrane lifts
were hybridized for 36 h at 68°C with subtracted cDNA probes
(106cpm/ml) in hybridization solution (5 x SSPE, 5x Denhardt's,
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100pg/ml ofsalmon spermDNA, and 10% dextran sulfate). The
filters were washed for 20 min with 2x SSPE 0.1% SDS twice
at room temperature and twice at 55°C. Positive plaques were
identified andrescreened with a second subtracted probe. The sec-
ondary clones were rescreened with a B cell cDNA probe or a T
cell cDNA probe. Those clones hybridizing with the B cell probe
but not the T cell probe were rescreened with Ig (IgG, IgM, u,
X, IgA) probes, andpositiveplaques were eliminated. Approximately
200clones were isolated that survived this screening. Theseclones
were further characterized by Northern blot analysis and partial
DNA sequencing. Clone 66 was one of these clones that was ex-
pressed in Bcellsandnot Tcells, andwasfound to be apreviously
uncharacterized gene. The original clone66 was used to rescreen
the B cell cDNA library, and 10 hybridizing clones were isolated.
Two clones, 66.2 and 66.5, were each 3.2 kb and were used for
further studies.
DNA Sequencing of BI-CAM and Analysis of Predicted Protein.
DNA sequencing was performed on double-stranded DNA tem-
plates usingthedideoxychaintermination techniquewith Sequenase
following the manufacturers protocols (U.S. Biochemical Corp.,
Cleveland, OH). Generated sequence information was used to syn-
thesizenewprimers to complete the sequencing. Oligonucleotides
were synthesizedusingan oligonucleotidesynthesizer (Applied Bio-
systems, Inc., Foster City, CA). Each strand of66.2 wassequenced.
Thesequencing projectwasperformedwith theaidof theAssemgel
program in PCGENE (Intelligenetics, Mountain View, CA). The
DNA (Genbank) and protein (NationalBiomedical Research Foun-
dation [NBRF]) data base searches and protein alignments were
performedwith theFASTA, FASTP, andAlign programs, respec-
tively (9, 10), at the Advanced Scientific Computing Laboratory
(Frederick, MD). The BIrCAM-predicted sequence was analyzed
with the aidof theProsite, Signal, andSOAP programs ofPCGENE
(Intelligenetics).
In Vitro Transcription and Translation.
￿
Capped RNA was syn-
thesized in a 25-A1reaction using as a substrate 2 gg of linearized
DNAfor 1 h at 40°C usingT3 or T7 RNApolymerase (Stratagene)
in the presence of RNasin. The capped mRNA transcripts were
visualized on aformaldehyde/agarose gel and found to be the ap-
propriate size. In vitro translation of the RNAs was done using
a rabbit reticulocyte lysate (Stratagene) in a 25-Al reaction using
10% of the capped mRNA in the presence of '6S-methionine. The
translation products were separated on a 8% SDS-PAGE gel and
visualized by autoradiography.
Plasmid Construction and Transient Expression in COS-7 Cells.
Recombinant66.2 was subclonedinto CDM8 in thesense and an-
tisenseorientations. A2.8-kb XhoI/SSPI insert of66.2 wasblunted
with Klenow fragment, linkered with BSTX1 linkers(Invitrogen,
San Diego, CA), andligated into the BSTX-1 site in CDM8. The
ligation mix was used to transform P3 cells. The termination sites
of the sense and antisense constructs were sequenced using the
dideoxy chain termination technique, whichconfirmed theorien-
tations. Therecombinant plasmids were purified on Qiagen columns
(Qiagen Inc., Studio City, CA) andused to transfect COS-7 cells
via electroporation (11) . 5 x 106 COS cells from a subconfluent
flask were washed with electroporation buffer (272 mM sucrose,
7 mM sodium phosphate, pH 7.4, and 1 mM MgCL2) andresus-
pended at 7 x 106 cells/ml in the same buffer. The cells were
transferred to a sterile 0.4-cm electroporation cuvette (Bio-Rad
Laboratories), and 100jA1of a 100-ttg/ml DNA suspension in elec-
troporation buffer was added. The cuvette was incubated on ice
for 10 min and then electroporated at 350 V and 25 microfarads
(WFD)with a Gene Pulser (Bio-Rad Laboratories). After pulsing,
thecells were returned to icefor10 min. Thecellswere resuspendedin DMEM/10% FCS and cultured at 37°C overnight. The fol-
lowing day, the cells were harvested with trypsin/EDTA and then
repeated in six-well tissue culture plates or slide chambers (LabTek
Products, Naperville, IL). 48 h later, the cells were used for FRCS
(FRCS is a registered trademark of Becton Dickinson & Co.) anal-
ysis or functional studies. For FACS analysis, the cells were har-
vested with versene and immunofluorescently stained with CD22
(HD6 and HD39; Boehringer Mannheim Biochemicals, Indi-
anapolis, IN) and a FITC-conjugated goat anti-mouse IgG (Tago
Inc., Burlingame, CA), and analyzed on a EPICS analyzer (Coulter
Electronics, Inc., Hialeah, FL). For functional studies, the trans-
fected COS cell monolayer was washed with DMEM without
serum; the test cells, in DMEM, were added in the presence or
absence of antibody; the cells were allowed to adhere for 1-2 h;
the monolayer was gently washed eight times with DMEM; and
the monolayer was examined with an inverted microscope. In some
cases, the transfected COS cell monolayer was directly stained with
CD22 or a control antibody followed by the developing antibody
and then visualized with an inverted fluorescent microscope.
Northern BlotsandIn Situ Hybridization.
￿
For northern blots, total
RNA was prepared by a guanidine thiocyanate method (12). The
RNA was size fractionated on 1% agarose/formaldehyde gel, trans-
ferred to nitrocellulose, LTV crosslinked, and hybridized in a
formamide-based hybridization solution at 42°C with random
primed, 32P-labeled cDNA inserts. The filters were washed twice
at room temperature in 2x SSC/0.1% SDS for 20 min and twice
at 55°C in 0.1x SSC/0.1% SDS, and exposed to film (12).
For in situ hybridization, a protocol was used similar to that
described by Pardue (13) for RNA hybridization. Paraffin-fixed tonsil
sections were mounted on silanized slides after which the slides
were deparaffinized, hydrated, and washed for 20 min in 0.1 M
HCl and followed by digestion with proteinase K (10 ug/ml) for
30 min. The slides were acetylated by treatment with acetic anhy-
dride in a 0.1 M triethanolamine buffer, pH 8.2, and prehybridized
at 45°C for 2 h in a solution of 50% formamide, 10% Denhardt's
solution, 0.5 mM EDTA, 10 mM Tris-HCI, 5 mM DTT, 0.3 M
NaCl, and 50 lAg/ml ofyeasttRNA. Hybridization was performed
in the same solution with the addition ofan equal volume of 20%
dextran sulfate in 50% formamide and probe at 8 x 10' cpm/ml.
1 ir1 of hybridization solution was used per 25 mmz of specimen.
Ordinary coverslips were sealed at the edges and the slides hybrid-
ized at 42°C. 'SS-labeled sense and antisense RNA probes were
made from the bluescript BIrCAM plasmid using the T3 (sense)
and T7 (antisense) promoters by Lofstrand Laboratories (Gaithers-
burg, MD). The probes were hydrolyzed in carbonate buffer to
a length of-300 bp. They were purified by repeated precipitation
with ethanol and had specific activities of -2 x 108 cpm/wg.
After overnight hybridization, the coverslipswere removed and the
slides were washed once in 50% formamide 1x SSC with 1 mM
EDTA and 5 mM DTT followed by five washes at 60°C with 2 x
SSC with EDTA and DTT followed by digestion of single-strand
RNA with RNase A and RNase T1. Slides were then washed in
0.3 M ammonium acetate in alcohol and dried overnight. Slides
were dipped in NTB2 emulsion (Eastman Kodak, Rochester, NY),
exposed for 3 d, and developed in Kodak D-19 diluted 1:1. Fixed
slides were stained with hematoxylin and eosin and examined at
100x with darkfield illumination on an adapted microscope (Carl
Zeiss, Inc., Thornwood, NY).
Results
Isolation ofClone 66 and DNA Sequence Analysis.
￿
A B lym-
phocyte cDNA library was constructed from mRNA purified
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from human B lymphocytes stimulated with SAC and PMA.
Approximately 20,000 clones were screened with subtrac-
tive cDNA probes generated from human B and T cell
mRNA. One of the isolated clones was found to hybridize
to a 3.3-kb mRNA present in total RNA isolated from B
cells but not from T cells. Partial DNA sequence analysis
and search of Genbank with the derived sequence informa-
tion did not reveal any significant homologies to known DNA
sequences. This clone was used to rescreen the cDNA library
and 10 clones were isolated, two o£ which appeared full length.
One of the clones, 66.2, was fully sequenced in both direc-
tions and the derived DNA sequence information is presented
in Fig. 1. Of note is a poly CA tract present in the 3' un-
translated portion of the cDNA. Similar poly CA tracts have
been found in a variety of other mRNAs, including the CEA
mRNA, and it is thought to function as a weak enhancer
element (14, 15). The clone 66.2 DNA sequence, although
extending further 5' and 3, is essentially identical to a cDNA
for CD22 isolated by Stamenkovic and Seed (5), with the
exception that their CD22 cDNA clonelacks 531 by present
in clone 66.2. The two sequences diverge at by 777 and reas-
sume identity at by 1308 in the BDCA MDNA sequence.
Analysis of the BIrCAM cDNA revealed an ATG-initiated
open reading frame of 2,541 bases, which encodes for a
predicted protein of 847 amino acids with a molecular mass
of 95 kD. In contrast, the published CD22 cDNA clone is
predicted to encode for a 67-kD protein (5). In vitro tran-
scription and translation ofthe BIrCAM cDNA demonstrated
a protein that migrated at a molecular mass of 95 kD on SDS-
PAGE (Fig. 2). The probable initiation ATG was followed
by a signal peptide predicted to be either 21 or 22 amino
acids. Hydrophobicity plots revealed the presence ofthe signal
peptide and a single membrane-spanning domain (amino acids
688-706) with a predicted intracytoplasmic region of 140
amino acids. Because of an additional G residue at by 2541
of the clone 66.2 cDNA, the predicted intracytoplasmic por-
tion of B1rCAM is 23 amino acids longer than predicted by
the Stamenkovic and Seed cDNA (5). The intracytoplasmic
region of BIrCAM has a predicted protein kinase C phos-
phorylation site (threonine 764), a casein kinase II phosphory-
lation site (threonine 789), and six tyrosines. None of the
intracytoplasmic tyrosines matches the consensus sequence
(R,K-x2-[E,D]-x3Y) for a tyrosine phosphorylation site, al-
though one of the sites, tyrosine 796, is a close approxima-
tion to the consensus with an arginine eight amino acids in-
stead of seven to the NH2-terminal side of the tyrosine. The
predicted extracytoplasmic portion of the molecule has 12
n-linked glycosylation sites, suggesting that the protein is
heavily glycosylated, and if all the sites are glycosylated, the
estimated molecular mass of the BITCAM protein would be
-140 kD, which is a close approximation of known molec-
ular mass of CD22 (16).
Expression ofBbCAM mRNA.
￿
To examine the expres-
sion of the BIrCAM mRNA in various cell types and to ex-
amine the effects of cytokines and B cell activation on BD
CAM expression, we performed a series of Northern blots.
A major 3.3-kb mRNA consistent with the size of the BL,
CAM cDNA was found to be well expressed in in vitro acti-vated normal B cells but to be expressed at low levels in B
cells freshly isolated from human tonsils (Fig. 3). No expres-
sion was found in tonsillar T cells or tonsillar T cells acti-
vated with PHA and PMA. A variety of B cell lines were
found to express the BLCAM mRNA, including the pre-B
cell line Nalm-6. Several B cell lymphoma cell lines expressed
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Figure 1.
￿
Sequence of the cDNA representing BLCAM transcript. Nucleotide sequence of a cDNA containing the entire coding and 3' untranslated
region of BLCAM. The amino acid sequence is numbered on the left and the nucleic acid sequence is numbered on the right. The in-frame termination
codons upstream of the predicted initiation site and at the end of the coding sequence are designated by three asterisks. The boundaries of the Ig
domains are indicated by numbers that correspond to the number of the domain from the NHZ terminus. Domains 3 and 4 are underlined. The trans-
membrane portion of BLCAM is underlined with a broken line. The polyadenylation signal beginning at adenosine 3221 is also underlined.
the 3 .3-kb BIrCAM transcript as well as several minor tran-
scripts. The minor transcripts are likely to be alternatively
spliced mRNAs. In contrast, none of the T cell lines, in-
cluding several human T cell leukemia type 1-transformed
lines, were found to express this mRNA. Additionally, no
significant hybridization signal was found with poly(A) RNA
CCATCCCATA 92CA000AM ACACGCGGAA ACAGGOTTGC ACCCAGACAC GAGCCATGC ATCTCCTCGG CCCCTGGCTC CTGCTCCTGG 90
1 *** 1[ H L L C P W L L L L
TTCTAQRATA CTTOOCSTTC TCTGACTCAA GTAAATGGGT TTTTGAGCAC CCTGARACCC TCTACGCCTG GGIIGGGGGCC TGCGTCTQGI 180
12 V L Z Y L A F 8 D 8 18 K N V 1 . Z R P Z T L Y A W Z G A C V K
TCCCCTQCAC CTACAA .A000 CTAGATCGTG ACCTGGAAAG CTTGTCCTG TTCCAC7NITC CTGIIGTATAA CAAGAACACC TCGAAGTTTG 270
42 I P C T Y A A L D G D L
Z .,8 .
F I L - F 8 N P Z Y N R N T 8 K F
ATGOQACAAG ACTCTATUA AOCACAAAGG ATGGQAACGT TCCTTCTGAG CAGAAAAGGG TQCAATTCCT GGGAGACAAC AATAAGARCT 360
72 D O T R L Y Z 8 T R D G K V P S Z Q II R V Q F L G D K N K N
GCACACTGIO TATCGCCCG GTOCACCTCA ATGACAGTGG TGGCTGGGG CTGAGGRTGG AVPCCAAGAC TGAGAAATGG ATGGAACGAA 450
102 C T L 8 1 H P V H L N D 8 G Q L G L R !1 Z 8 R T Z K if M Z R
TACRCCTCIA TMTC IIOGCCTTTTC CACCTCATAT CGGCTCCCT CCAGAAATTC AAGAGTCCCA GGAAGTGCT CTGACCTOCT 540
132 I H L N V 8 Z R P F P P H I Q L P P Z I Q Z 8 Q Z V T L T C
TOCT"AT" CTCCTGMAT GOOTATCCGA TCCRATTGCA GTGGCTCCTA GAGGGGGTTC CAATGA=CA GGCTGCTGTC ACCTCGACCT 630
162 L L N F 8 C Y G Y P I Q L Q W L L Z G V P Y A Q A A V T 8 T
CCTTQ&CGT CAAGTCTOTC TTCACCCGGA GCGAGCTCAA GTTCTCCCCA CAGTGGAGTC ACCATGGGAA GATTGTGACC TGCCAGCTTC 720
192 S L T I R 8 V F T A 8 Z L K F 8 P Q W 8 H H G K I V T C Q L
AOGITOCAGA TGOGAAGTTC CTCTCCAATG ACACGGTGCA GCTGAACGTG OCC CGAAGTTGGA GATCAAGGTC ACTCCGGTG 810
222 Q D A D O R F L 8 N D T V Q L N V K H23T P K L Z I K V T P 8
ATOCCATAGT GAOOGUOGOG GACTCTGTGA CCATGACCTG CGAGGTCAGC AGCAGCAACC C TALC GACGGTAT C TGGCTCAAGO 900
252 D A I V A Z O D 8 V T N T C Z V 8 8 8 N P Z Y T T V 8 W L K
ATOOGRCCTC OCTQAAGAAG CAGAATACRT TCACGCTAAA CCTGCGCGAA GTGRCCIUIGG ACCAGAGTGG GAAGTACTGC TGTGGGTCT 990
282 D O T 8 7._R Q N T F T L N L A Z V T K D Q 8 G K C V
GGIAG AAGTGTTCCT GCAAGTGCAG TA CCCCGG AACCTTCCAC GGTT
E&
TC CTC
S_&
TCAC 1080
312 8 N D V G P O R 8 Z Z V F L Q V Q Y A P Z P 8 T V Q I L H 8
COGCTOTO" OOGRAQTCAR OTCGAGTTTC TTTGGTGTC ACTGGCCAAT CCTCTTCCAA CAAATTACAC GTGGTACCAC AATGGGAAAG 1170
342 P A V Z MOM" V Z F L C 11 8 L A 1( P L P T N Y T W Y H N G K
AAi3O~ S QRGAAAGTTCCC ACA CCCAAA GR CCTCCCC TGOCACGCTG GGACTTATTC CTGT GARAAGTTC 1260
372 Z II O A T Z Z K V N I P K I L P if H A G T Y 8 C V A Z N I
~C'1'OO CCOGGROma AGCTGGATGT CCA12TATCCT CCCRAGAAGG TGACCACACT GATTCAAAAC CCCATGCOGA 1350
402 L O T O A O P G A Z L D V Y~1SP P R K V T T V I Q N P M P
ACCCTTTCCT GTAACTACAA TTCCAGTAAC CCCAGTOTTA CCCGGTATGA ATGGAIRACCC CATGGCGCCT 1440
432 I R Z O D T V T L 8 C N Y N 8 8 N P 8 V T R Y Z W K P H G A
GOGRGGAOCC ATCOMTGOO GTGCTGRA" TCCAAAACGT TGGCTGGGAC ARCACAACCA TCGCCTGCGC ACGTTGTAAT AGTTGGTGCT 1530
462 W Z Z P 8 L 0 V L K I Q N V G W D N T T I A C A R C N S W C
CVPOQOCCTC CCCTOTCOCC CTGAATGTCC AGTATC000C CCGAGACGTG AGGGTCCGGA AAATCAAGCC CCTTTCCGAG ATTCACTCTG 1620
492 8 V A 8 P V A L N V Q Y5 A P R D V R V R K I K P L 8 Z 1 H S
GRRACTCOGT CAOCCTCCAA TGTGRCTTCT CLAGCAGCCA CCCCAAAGAA GTCCAGTTCT TCTGGGAGAA AAATGGCAGG CTTCTGGGGA 1710
522 0 N 8 V 8 L Q C D F 8 S S H P K Z V Q F F W Z K N G R L L G
ARORRhOCCA OCTOARTM GACTCCATCT CCCCAGAAGA TGCTGGGAGT TACAGCTGCT GGGTGAACAA CTCCATAGGA CAGACAGCGT 1800
552 K Z 8 Q L N F D 8 I 8 P Z D A G S Y 8 C W V N N S I G Q T A
CCAAOOCCTG GRCRCTTGAA GTGCTCTA G CACCCAGGAG GCTGCGTGTG TCCATGAGCC CGGGGGACCA AGTGATGGAG GGGAAGAWG 1890
582 8 K A A T L Z V L Y~ 7A P R R L R V 8 N 8 P G D Q V M Z G K 8
CAACCCTGAC CTOTOAQAOT GACOCCAACC CTCCCGTCTC CGCTACACC TGGTTTGACT GGAATAACCA )WGCCTCCCC CACCAGGCC 1980
612 A T L T C Z 8 D A N P P V 8 H Y T W T D W N N Q S L P R H 8
AGAR00TGLO ATTOGAOCCG GTORAOOTCC AGCACTCGGG TGCCTACTGG TGCCAGGGGA CCAACAGTGT GGOCAAGGGC CGTTCGCCTC 2070
642 Q R L R L Z P V R V Q H 8 G A Y W C Q G T N S V G K G R 8 P
TGOCACCCT TACTOTCTAC TATAGCCCGG AGACCATCGG CAGGCGAGTG GCTGTGGGAC TCGGGTCCTG CCTCGCCATC CTCATCCTGG 2160
672 L 8 T L T V Y Y7 8 P Z T I G R R V A V G L G S C L A I L I L
CAAmwTOG Omc"OCTC CAOCGACGTT GGmr cGm ACAGAGCCAGCACGGGCTTC AGGAGAATTCCAGCGGCCAG AGCTTCTTTG 2250
702 A I C O L R L Q R R W X R T Q 8 Q Q G L Q Z N 8 8 G Q S F F
TQJOR ' A A 3OTTA" AOGCCCCCCC TCTCTGAAGG CCCCCACTCC CTGGGATGCT ACAATCCAAT GATGGAAGAT GGCATTAGCT 2340
732 V R N R K V R R A P L S Z G P H 8 L G C Y N P M M Z D G I 8
ACACQACCCT OCOCTTTCCC GAOATGAACA TACCACGAAC TGGAGATGCA GAGTCCTCAG AGATGCAGAG ACCTCCCCGG ACCTGCGATG 2430
762 Y T T L R F P Z !I N I P R T G D A Z S S Z N Q R P P R T C D
ACACOOTCAC TTATTCAGCA TTGCACAAGC GCCAAGTGGG CGACTATGAG AACGTCATTC CAGATTTTCC AGAAGATGAG GGGATTCATT 2520
792 D T V T Y 8 A L N R A Q V G D Y Z N V I P D F P Z D Z G I H
ACTCRGAOCT GATCCACTTT GGGGTCGGGG AGCGGCCTCA GGCACAAGAA AATGTGGACT ATGTGATCCT CAAACATTGA CACTGGATGG 2610
822 Y 8 Z L 1 Q F G V G Z R P Q A Q Z N V D Y V I L K H ***
OC"CAOCGG AOGCKCTOOG QQCAQCGQGG GCGGGGAAG TCCCCGAGTT TCCCCAGACA CCGCCACATG GCTTCCTCCT CCGTGGTGT 2700
GOWRCICRC AC&CACACAC QCRCACAGC ACACACACAC TCACTGCGGA GAACCTTGTG CCTGGCTCRG AGCCAGTCTT TTTGGTGAGG 2790
OTARCCOCRA RCCTCC"RA CTCCTOCCCC TGTTCTCTTC CACTCTCCTT GCTACCCAGA AATCATCTAA ATACCTCCCC TGACATGCAC 2880
ACCTCQCCTO OCCCACCROC CCACTOOCCA TCTCCACCCG GAGCTGCTGT GTCCTCTGGA TCTOCTCGTC ATTTTCCTTC CCTTCTCCAT 2970
CTCTCT000C CTCTACCCCT GATCTQACAT CCCCACTCAC GAATATTATG CCCAGTTTCT GCCTCTGAGG GAAAGCCCAG AAAAGGACAG 3060
AAAOOMMA G"AOOmm CAOTCCTGGC CTGGCTTCTC CTTTGGRAGT GAGGCATTGC ACGGGGACAC GTACOTATCA GCGGCCCCTT 3150
QwmT0000 ACTCCOOGTT TCAGAwr .AC ACA.CTGGTGT GGATTAACCT GCCAGGGAGA CAGAGCTCAC AATAARAATG GCTCAGATGC 3240
CACTTCAARG AAAAAAARRAFigure 2 . In vitro transcription and
translation ofBLCAMcDNA . TheBL
CAMBluescript plasmid was linearized
with XhoI and in vitro transcribed using
the T3 (sense) promoter or the T7 (an-
tisense) promoter. TheBLCAM sense or
antisense RNA was in vitro translated
using a rabbit reticulocyte system and
35S-methionine. The translated products
using the sense (lane 1) or the antisense
(lane 2) were analyzed on a 10% poly-
acrylamide and visualized by fluorography.
derived from Hela cells, brain, or placenta (Fig. 3) . The effects
of several cytokines on normalB lymphocyte expression was
also examined . Neither IL-4, IL-6, TNF-a, nor IFN-y en-
hanced expression of BL-CAM ; however, treatment of the
Figure 3.
￿
The expression ofBLCAM in various tissues, cell lines, and
normalBandTlymphocytes. Total RNAwas prepared from various tissues,
lymphoid cell lines, and normal BandT cells . In somecases, poly(A) RNA
was prepared. Each lane contains 15 ug of totalRNA or 2Rg of poly(A)
RNA; each of the cell lines is indicated below their respective lane (top) .
The normalB cells were prepared from tonsils and in vitro activated with
SAC andPMA for the indicated time periods (bottom, left) or incubated
with 1,000U/ml of114, 1 ng/ml ofTNF-a, 100 U/ml 11,6, 1,000U/ml
of IFN- .y, or SAC/PMA for 24 h (bottom, right) .
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tonsillar B cells with SAC and PMA significantly increased
its expression (Fig . 3) .
Homologies to Other Proteins and Domain Structure.
￿
Similar
to Stamenkovic and Seed (5), we also noted the similarity
of our clone 66.2, BLCAM, to myelin-associated glycopro-
tein (MAG) . When the BITCAM-predicted protein was used
to search the NBRF protein database using theFASTP search
program, it revealed very significant homologies with MAG
and carcinoembryonic-associated antigen (CEA) . The first 420
amino acids of BL-CAM (two gaps) aligned with the first
414 amino acids of MAG (four gaps) were 27% identical .
Amino acids 222-684 of BLCAM (11 gaps) aligned with
amino acids 168-596 ofCEA (eight gaps) were 29.5% iden-
tical (Table 1) . If conservative amino acid substitutions are
included in the analysis BL-CAM andMAG are64% similar,
while BL-CAM and CEA are 71% similar over the above
regions . Both MAG and CEA are members of the Ig super-
family, and both function as adhesion molecules (17-21). CEA
has been modeled and is predicted to contain seven domains
with one N1-12-terminal Vlike domain and six C region-like
domains, andMAG has been predicted to contain one NH2-
terminalVlike domain four C region domains (22, 23) . Simi-
larly, BL-CAM appears to have a single NH2-terminal Vlike
domain and six C region-like domains . The first two do-
mains each have -110 amino acids, while the other domains
have -90 amino acids each . The first three domains contain
three cysteines, while all the other domains contain two cys-
teines, except domain 5, which contains four cysteines . There
are some similarities between the domains, particularly do-
Table 1 .
￿
Proteins Related to BL-CAM
The NBRF protein data base was searched with the BL-CAM amino
acid sequence using the FASTP-Lipman-Pearson algorithm, and the eight
proteins with the best scores are listed above . Each of the proteins was
aligned with BL-CAM using the Align algorithm, and the percent amino
acid identity over the aligned portions of the proteins was determined .
Protein
Optimized
alignment score
Amino
acid identity
Myelin-associated
glycoprotein 361 25.9 over 425 as
Carcinoembryonic antigen 338 29.5 over 462 as
Bilary glycoprotein I 221 22.4 over 308 as
Nonspecific crossreactive
antigen 187 32.6 over 138 as
Myeloid cell surface
antigen CD33 184 25 .2 over 266 as
IgG Fc receptor 159 19.6 over 275 as
Carcinoembryonic antigen-
related protein 158 19 .9 over 287 as
Neural cell surface
adhesion molecule 150 21.5 over 266 asFigure 4 .
￿
In situ hybridization with BLCAM RNA probe. 35S-methionine-labeled antisenseBLCAMRNA was hybridized to human tonsil tissues
and then stained with hematoxylin . A was photographed with visible light and B was photographed using dark field illumination . When viewed
with dark field illumination, a positive signal is light while a negative signal is dark .
mains 3-7 . The best match is between domains 3 and 7, which
are 33% identical. TheCD22cDNA cloned by Stamenkovic
and Seed (5) lacks domain 3 and 4 of BL-CAM .
When the intracytoplasmic portion ofBL-CAM was used
to search theNBRF protein data base or the translated Gen-
bank data base, no significant homologies with other pro-
teins were found . The multiple phosphorylation sites sug-
gest that it is a phosphoprotein, but whether or not it has
a role in intracellular signalling is currently unknown .
Analysis ofBLCAM Expression by In Situ Hybridization .
￿
To
characterize the expression ofBL-CAM mRNA in vivo, we
used in situ hybridization to localize itsmRNA in a variety
of different tissues . 31S-methionine sense and antisense RNA
probes were made and sheared to 200-300 bases . In situ hy-
bridization with paraffin-fixed tissues was performed . No
significant hybridization signal was found with liver, placenta,
kidney, or small intestine, either with the sense or the an-
tisenseRNA (data not shown) . However, when either tonsil
or lymph node tissue was used, a clear hybridization signal
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was found with the antisense probe but not with the sense
probe . The strongest signal in both thelymph node and tonsil
was in germinal centers, and a less intense although clearly
present signal was present in the mantle zone ; both regions
are highly enriched with B lymphocytes (Fig. 4) .
Expression ofBLCAM in COS Cells and Evidence it Func-
tions as a Cell Adhesion Molecule. Since theBL-CAM protein
was predicted to be an integralmembrane protein, we deter-
mined whether anyknownmAbs reacted with the expressed
protein . The full-lengthBLCAMcDNA was subcloned into
the CDM8 vector in the sense and the antisense direction .
Both constructs were transfected intoCOS cells via electropo-
ration . 72 h later, the COS cells were immunofluorescently
stained with a variety ofB cell mAbs, including two CD22
antibodies that recognize different epitopes, and analyzed by
fluorescent microscopy and FACS. Examination of the stained
COS cells with the fluorescent microscope revealed clear
staining of ti5% of the cells with the CD22 antibody (data
not shown) . FACS analysis also demonstratedCD22 staining
Figure 5 .
￿
Expression ofBLCAM inCOS cells
and reactivity with CD22 antibodies . COS cells
were transiently transfected with sense or antisense
BLCAM CDM8 constructs via electroporation,
and 3 d later, immunofluorescently stained with
CD22 antibodies and analyzed by a FACS.of theCOS cells transfected withBLCAM in the sense direc-
tion but not in the antisense direction (Fig. 5) . When the
antibodies were used individually rather than together, both
antibodies were found to immunofluorescently stain theCOS
cells transfected with the sense BITCAM construct (data not
shown) .
We next tested the hypothesis that BLCAM mediates B
cell-B cell adhesion . COS cells were transfected with the BL
Figure 6 .
￿
Adherence of B cells to COS cells transfected
withBLCAMcDNA . COS cells were transiently transfected
with senseor antisenseBLCAMCDM8 constructs via elec-
troporation . 3 d later, the monolayer was overlayed with B
cells, washed extensively, examined by inverted microscope
for the presence of adherent cells, and photographed . BL
CAM-transfected COS cells were overlaid with HS-Sultan
cells (A and B) . Antisense-transfected COS cells were over-
laid with tonsil B cells (C) . BLCAM-transfected COS cells
were overlaid with tonsil B cells (D and E) . BLCAM-
transfected COS cells were overlaid with tonsil B cells previ-
ously immunofluorescently stained with CD20 and exam-
ined by fluorescent microscopy (F) .
CAM expression vector in both the sense and the antisense
directions. 72 h later, the transfected COS cells were overlaid
with HS-Sultan, a B cell line that expressed high levels of
CD22, with Jurkat, a T cell line, or with normal tonsillar
B lymphocytes. The normal B cells and the HS-Sultan cell
line were found to adhere to the COS cells transfected with
BLCAM in the sense orientation (Fig . 6, A, B, and D-F),
but not in the antisense orientation (Fig. 6 C) . The addition
Figure 7 .
￿
Correlation between expression ofBLCAM by transfected COS cells and adhesion of B cells. COS cells were transiently transfected with
the sense BLCAM construct, immunofluorescently stained with a CD22 antibody, overlaid with purified tonsillar B cells, washed, and examined by
a inverted microscope for B cell adhesion (A) and fluorescence (B) . A was photographed to demonstrate B cell adhesion, and the identical field was
photographed to reveal concurrent expression ofBLCAM by immunofluorescence.
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the detachment of some of the COS cells, and direct B cell
COS cell conjugates were observed (Fig. 6 B). The tonsillar
cells adherent to the COS cellswere shown to be B lympho-
cytes by immunofluorescent staining with CD20 before the
adhesion step. The cells adherent to the COS cell monolayer
were examined with a fluorescent microscope (Fig. 6 F) . The
Jurkat cells failed to adhere to BIrCAM-transfected COS cells
(data not shown). While the differencebetween the antisense-
transfected and BLCAM-transfected cells was striking, the
addition of CD22 antibodies failed to inhibit the binding of
the HS-Sultan or tonsil B cells to the transfected COS cells.
A variety of other antibodies also failed to inhibit the B cell
binding, including LFA-1, CD44, and ICAM-1 (data not
shown). The failure of CD22 antibodies to inhibit binding
of the B cells to the transfected COS cells allowed us to im-
munofluorescently stain the COS cell monolayer with CD22
before adherence of the B cells. There was a nearly 1:1 corre-
lation between the COS cells that bound B cells and the ex-
pression of CD22 (Fig. 7). Thus, although the transfection
data were not conclusive, since the CD22 antibodies failed
to block the binding of the B cells, it strongly suggests that
one of the functions of BLCAM, CD22, is to mediate B
cell-B cell interactions.
Discussion
Using subtractive hybridization, we have isolated several
cDNAs that identify mRNAs expressed in B cells and not
in T cells. One of these clones (clone 66.2) has been fully
sequenced and found to encode CD22, a B cell membrane
glycoprotein, which is likely to have a role in B cell-B cell
interactions and is referred to as BLCAM. The predicted BL
CAM protein core has a molecular mass of 95 kD, and in
vitro transcription and translation of BLCAM followed by
analysis by SDS-PAGE confirmed thepredicted molecular mass
and agrees with the known molecular mass ofdeglycosylated
CD22 (24, 25). Analysis of the predicted protein revealed
some interesting structuralfeatures and homologies with pre-
viously characterized proteins, and in addition, gave some
insights into the probable function ofthis protein. Functional
studies in COS cells transfected with BLCAM suggest that
it functions as an adhesion protein mediating B cell-B cell
interactions. These data support and extend the observations
made by Stamenkovic and Seed (5).
DNA sequence analysis of clone 66 revealed a 3,260-bp
insert and a predicted open reading frameof 847 amino acids.
Salient features of the predicted BLCAM protein included
a signal peptide of 21 amino acids, a transmembrane domain
of 19 amino acids, and an intracytoplasmic portion of 140
amino acids. The extracytoplasmic portion can be divided
into 7 lg region-like domains of 90-110 amino acids each.
The first three domains have an unpaired cysteine residue that
could form an intra-chain disulfidebond. Each ofthe remaining
domains contain two rysteine residues, except for domain 5,
which has four rysteine residues. The extracytoplasmic por-
tion of BL-CAM is related to several other Ig-like proteins;
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the most striking homologies on search ofprotein data bases
were the similarities with CEA and MAG. Interestingly, the
first 425 amino acids ofMAG aligns with 26% identity with
domains 1-4 ofBLCAM, while CEA aligns with 29% iden-
tity with domains 3-7 of BLCAM, thus encompassing the
entire extracytoplasmic portion of BLCAM. When conser-
vative amino acid changes are included in the analysis, MAG
and BLCAM are 64% and CEA and BLCAM are 71% ho-
mologous over these regions. Several other proteins including
bilary glycoprotein 1, pregnancy-associated glycoprotein, and
nonspecific crossreactive antigen, are members ofthe Ig super
family and are closely related to CEA (50-90% identical at
the amino acid level), suggesting that these proteins form
a family within the Ig super family (26) . While MAG and
BLCAM are more diverged from CEA than these otherpro-
teins, their similarity to CEA suggests they may have arisen
from a common precursor.
Search of protein databases with the amino acid sequences
of the predicted intracytoplasmic domain of BLCAMfailed
to identify any relationship to previously characterized in-
tracytoplasmic region of known proteins. However, it does
have predicted protein kinase C and casein kinase II phos-
phorylation sites. In addition, there are six intracytoplasmic
tyrosines, one ofwhich is a close match with the consensus
for a tyrosine phosphorylation site. These findings suggest
some role for the intracytyoplasmic region of BLCAM in
signaling. To date, studies with CD22 antibodies have sug-
gested that CD22 may be involved in B cell activation. CD22
antibodies augment entry of B cells into the cell cycle and
further increase anti-Ig-induced rises in intrathymic Cat+
levels (27, 28). Additionally, preliminary studies indicate B
cell activation is associated with changes in the phosphoryla-
tion status of CD22 (22).
Previous studies with the CD22 antibody have shown that
it is expressed on 50-75% of EBVtransformed B cell lines,
50% of B cell lymphomas, and nearly 100% of hairy cell
leukemia cells (16) . Additionally, B cell differentiation is as-
sociated with the loss of CD22 (16). The reasons for this
variable expression are unclear, but it will be of interest to
characterize the mRNA transcript present in these various
cell lines and primary tumors. BLCAM mRNA expression
was examined in five EBVtransformed B cell lines and was
present in three cell lines that were CD22 positive, and nega-
tive in two cells that were CD22 negative. The predominant
BLCAM mRNA in the positive cells was the 3 .3-kb tran-
script. Interestingly, the expression of BIrCAM correlated
with the expression ofLFA1. The two cell lineswhich were
BLLCAM negative also expressed low levels of LFA1, sug-
gesting that these two genes may be coordinately regulated.
These BLCAM-negative, low LFA1-expressing cells were
strongly PNA positive, suggesting that neither LFA-1 nor
BI.rCAM accounts for the peanut agglutinin positivityofger-
minal center B cells (29). Of note, these cells grew in culture
as single cells rather than in the large clumps typically seen
with EBVtransformed cell lines (J. Kehrl, unpublished ob-
servations). We have isolated genomic clones for BLCAM
in order to characterize the promoter region that should help
to address the nature of these differences in expression. TheEBVtransformed B cell lines that do or do not express BL
CAM mRNA will be particularly useful in characterizing
the promoter region of this gene.
Several lines ofevidence support an important role for BL
CAM in interactions between human B cells. BLCAM is
a member of the Ig super family and is highly related to CEA
and MAB, two proteins known to mediate homotypic cell
adhesion (19-21), suggesting a similar role for BL-CAM in
B cells. The expression of CD22 in vivo is also consistent
with a role for CD22 in maintenance of the cellular architec-
ture in B cell-rich regions. The levels ofCD22 are relatively
low in peripheral blood B cells and increased in tissue-based
B cells (e.g., in the mantle region surrounding germinal center
in tonsils and lymph nodes) . The quantities of cell adhesion
molecules on the cell membrane are an important parameter
in theirfunctional capacity to mediate adhesion. Small changes
in surface density can lead to large changes in binding rates
(30). Immunocytochemistry with CD22 antibodies has also
demonstrated considerable expression in germinal centers, al-
though less striking than in the mantle region (16). More
direct evidence for BLCAM as a B cell adhesion molecule
was obtained by transfection of a BLCAMexpression plasmid
into COS cells. Strongly CD22-positive B cells adhered to
the transfected COS cells but not to COS cells transfected
with a plasmid in which BL-CAM was oriented in the oppo-
site direction. However, the binding was not inhibited by
two CD22 antibodies that recognize two different epitopes.
The failure of these antibodies to inhibit binding is likely
due to the recognition of an epitope that is not involved in
binding. Although our data suggest that BL-CAM is a homo-
typic cell adhesion molecule (i.e., BLCAM is both a ligand
and a receptor), it is not conclusive and awaits further studies.
Preliminary studies with a B cell line transfected with BL
CAM suggests that BL-CAM may mediate B cell adhesion
via direct interaction with itself (J. Kehrl, unpublished ob-
servation). Additionally, based on the adhesion assays per-
formed by Stamenkovic and Seed (5), BL-CAM in the ab-
sence of domains 3 and 4 can interact with other cell surface
molecules that are present on monocytes and mouse erythro-
cytes. The failure of Stamenkovic and Seed (5) to observe B
cell adhesion with peripheral blood B cells may be related
to a different conformation of the CD22 molecule due to
the lack ofdomains 3 and 4. Alternatively, ifCD22 is a homo-
typic cell adhesion molecule and interacts with other CD22
molecules on opposing cells, the relatively low levels ofCD22
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